Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 24;12(6):798.
doi: 10.3390/genes12060798.

Detection of Cryptic Fragile X Full Mutation Alleles by Southern Blot in a Female and Her Foetal DNA via Chorionic Villus Sampling, Complicated by Mosaicism for 45,X0/46,XX/47,XXX

Affiliations
Case Reports

Detection of Cryptic Fragile X Full Mutation Alleles by Southern Blot in a Female and Her Foetal DNA via Chorionic Villus Sampling, Complicated by Mosaicism for 45,X0/46,XX/47,XXX

Alison Pandelache et al. Genes (Basel). .

Abstract

We describe a female with a 72 CGG FMR1 premutation (PM) (CGG 55-199) and family history of fragile X syndrome (FXS), referred for prenatal testing. The proband had a high risk of having an affected pregnancy with a full mutation allele (FM) (CGG > 200), that causes FXS through hypermethylation of the FMR1 promoter. The CGG sizing analysis in this study used AmplideX triplet repeat primed polymerase chain reaction (TP-PCR) and long-range methylation sensitive PCR (mPCR). These methods detected a 73 CGG PM allele in the proband's blood, and a 164 CGG PM allele in her male cultured chorionic villus sample (CVS). In contrast, the Southern blot analysis showed mosaicism for: (i) a PM (71 CGG) and an FM (285-768 CGG) in the proband's blood, and (ii) a PM (165 CGG) and an FM (408-625 CGG) in the male CVS. The FMR1 methylation analysis, using an EpiTYPER system in the proband, showed levels in the range observed for mosaic Turner syndrome. This was confirmed by molecular and cytogenetic karyotyping, identifying 45,X0/46,XX/47,XXX lines. In conclusion, this case highlights the importance of Southern blot in pre- and postnatal testing for presence of an FM, which was not detected using AmplideX TP-PCR or mPCR in the proband and her CVS.

Keywords: 45,X0/46,XX/47,XXX; CGG; FMR1; X syndrome; cultured chorionic villus; fragile; full mutation; mosaicism; sample; southern blot.

PubMed Disclaimer

Conflict of interest statement

David E. Godler is named as an inventor on patent applications (PCT/AU2010/000169 and PCT/AU2014/00004) related to the technology described in this article. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Pedigree of the studied family with CGG sizing determined using an AmplideX TP-PCR. Males are represented by squares, females by circles and triangle sex unknown. A black outline indicates examined and half shaded indicates carrier. A black arrow indicates proband. III:1 Miscarriage at 6 of 40 weeks; (B) AmplideX TP-PCR CGG sizing, with no FM alleles detected in either III:3 male CVS or II:2 proband; (C) II:2 and (D) III:3 AmplideX mPCR, with the upper panel in blue representing CGG sizing based on control digestions and the lower panel in green representing relative methylation based on HpaII methylation sensitive restriction enzyme-based digestion followed by long-range PCR. No FM alleles are detected in either III:3 male CVS or II:2 female. Skewed methylation for the 75 CGG PM allele is suggested by 80% methylation. Note: numbers on each panel next to specific peaks indicate CGG sizes.
Figure 2
Figure 2
(A) Pedigree of the studied family with CGG sizing determined using Southern blot and standard CGG sizing PCR. Males are represented by squares, females by circles and triangle sex unknown. The black outline indicates examined, half shaded indicates carrier, and full shaded indicates affected with FXS. The black arrows indicate proband and a diagonal line indicates being deceased. III:1 Miscarriage at 6 of 40 weeks (B) Southern blot Lane 1 (male PM control), Lane 2 (III:3 male PM/FM CVS), Lane 3 (II:2 PM/FM female), Lane 4 (male normal CGG size control).
Figure 3
Figure 3
G banded chromosome analysis of II:2 proband blood and conventional karyotypes identify mosaic cell lines. (A) 45,X0 was found in 38/60 karyotypes analysed; (B) 47,XXX was found in 19/60 karyotypes analysed; (C) 46,XX was found in 3/60 karyotypes analysed. (D) Diagram of post zygotic nondisjunction and generation of the mosaic cell line 45,X[38]/47,XXX[19]1/46,XX[3]3.
Figure 4
Figure 4
Linkage analysis using chromosomal microarray. (A) Single nucleotide polymorphisms (SNP) duo image for chromosome 1 showing identity by state (sharing one allele) for the whole chromosome. Whole genome comparison confirmed child-parent relationship. Note: Chromosome 1 SNPduo Output A_Culture CVS–B_Proband Mother Average Identity by State (IBS):1.84; (B) SNP duo for chromosome X between the foetus and the X0 cell line showing IBS0, that is sharing no alleles for most of the chromosome including the FMR1 gene. Note: Chromosome X SNPduo Output A_Cultured CVS–B_Proband Mother Average IBS:1.1.547.

Similar articles

Cited by

  • C9orf72 repeat expansion creates the unstable folate-sensitive fragile site FRA9A.
    Mirceta M, Schmidt MHM, Shum N, Prasolava TK, Meikle B, Lanni S, Mohiuddin M, McKeever PM, Zhang M, Liang M, van der Werf I, Scheers S, Dion PA, Wang P, Wilson MD, Abell T, Philips EA, Sznajder ŁJ, Swanson MS, Mehkary M, Khan M, Yokoi K, Jung C, de Jong PJ, Freudenreich CH, McGoldrick P, Yuen RKC, Abrahão A, Keith J, Zinman L, Robertson J, Rogaeva E, Rouleau GA, Kooy RF, Pearson CE. Mirceta M, et al. NAR Mol Med. 2024 Nov 12;1(4):ugae019. doi: 10.1093/narmme/ugae019. eCollection 2024 Oct. NAR Mol Med. 2024. PMID: 39669124 Free PMC article.
  • Fragile sites, chromosomal lesions, tandem repeats, and disease.
    Mirceta M, Shum N, Schmidt MHM, Pearson CE. Mirceta M, et al. Front Genet. 2022 Nov 17;13:985975. doi: 10.3389/fgene.2022.985975. eCollection 2022. Front Genet. 2022. PMID: 36468036 Free PMC article. Review.
  • Editorial for the Fragile X Syndrome Genetics Special Issue: May 2023.
    Godler DE, Brown WT. Godler DE, et al. Genes (Basel). 2023 May 25;14(6):1148. doi: 10.3390/genes14061148. Genes (Basel). 2023. PMID: 37372328 Free PMC article.

References

    1. Hunter J., Rivero-Arias O., Angelov A., Kim E., Fotheringham I., Leal J. Epidemiology of fragile X syndrome: A systematic review and meta-analysis. Am. J. Med. Genet. A. 2014;164A:1648–1658. doi: 10.1002/ajmg.a.36511. - DOI - PubMed
    1. Godler D.E., Amor D.J. DNA methylation analysis for screening and diagnostic testing in neurodevelopmental disorders. Essays Biochem. 2019 doi: 10.1042/EBC20190056. - DOI - PubMed
    1. Godler D.E., Inaba Y., Schwartz C.E., Bui Q.M., Shi E.Z., Li X., Herlihy A.S., Skinner C., Hagerman R.J., Francis D., et al. Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis. Expert Rev. Mol. Med. 2015;17:e13. doi: 10.1017/erm.2015.11. - DOI - PMC - PubMed
    1. Godler D.E., Tassone F., Loesch D.Z., Taylor A.K., Gehling F., Hagerman R.J., Burgess T., Ganesamoorthy D., Hennerich D., Gordon L., et al. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum. Mol. Genet. 2010;19:1618–1632. doi: 10.1093/hmg/ddq037. - DOI - PMC - PubMed
    1. Irwin S.A., Galvez R., Greenough W.T. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb. Cortex. 2000;10:1038–1044. doi: 10.1093/cercor/10.10.1038. - DOI - PubMed

Publication types

Substances